Evidence map›Paper›PMID 36745588›Full record

ArticlePloS one2023

Profiles of COVID-19 vaccine hesitancy by race and ethnicity in eastern Pennsylvania.

Kenya M Colvin, Kennedy S Camara, Latasha S Adams, Adline P Sarpong, Danielle G Fuller, Sadie E Peck, Anthony S Ramos, Ariana L Acevedo, Meless A Badume, Shae-Lyn A Briggs and 16 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 1 country.

Kenya M ColvinGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.ORCID 0000-0002-7847-3858
Kennedy S CamaraGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Latasha S AdamsGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Adline P SarpongGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Danielle G FullerGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Sadie E PeckGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Anthony S RamosGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Ariana L AcevedoWilkes University, Wilkes-Barre, Pennsylvania, United States of America.
Meless A BadumeSwarthmore College, Swarthmore, Pennsylvania, United States of America.
Shae-Lyn A BriggsWilkes University, Wilkes-Barre, Pennsylvania, United States of America.
Tiffany N ChukwurahTemple University, Philadelphia, Pennsylvania, United States of America.
Zanett Davila-GutierrezTemple University, Philadelphia, Pennsylvania, United States of America.
James A EwingTemple University, Philadelphia, Pennsylvania, United States of America.
Jemimah O FrempongTemple University, Philadelphia, Pennsylvania, United States of America.
Amirah A GarrettTemple University, Philadelphia, Pennsylvania, United States of America.
Steven J GramppGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Jahasia W GillespiePennsylvania State University, Scranton, Pennsylvania, United States of America.
Emmanuel J HerreraTemple University, Philadelphia, Pennsylvania, United States of America.
Shantia M E HorsfordGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Emis J MaddoxUniversity of Scranton, Scranton, Pennsylvania, United States of America.
John C PelaezSusquehanna University, Selinsgrove, Pennsylvania, United States of America.
Olivia L QuarteyTemple University, Philadelphia, Pennsylvania, United States of America.
Fanny RodriguezUniversity of Scranton, Scranton, Pennsylvania, United States of America.
Luis A VasquezUniversity of Scranton, Scranton, Pennsylvania, United States of America.ORCID 0000-0003-2866-7379
Brian J PiperGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.
Swathi GowthamGeisinger Commonwealth School of Medicine, Scranton, Pennsylvania, United States of America.ORCID 0000-0002-5586-6122
Geisinger Commonwealth School of Medicine · USTemple University · USUniversity of Scranton · USWilkes University · USGeisinger Medical Center · USSusquehanna University · USSwarthmore College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThroughout US history, chronic and infectious diseases have severely impacted minority communities due to a lack of accessibility to quality healthcare and accurate information, as well as underlying racism. These fault lines in the care of minority communities in the US have been further exacerbated by the rise of the COVID-19 pandemic. This study examined the factors associated with COVID-19 vaccine hesitancy by race and ethnicity, particularly among African American and Latinx communities in Eastern Pennsylvania (PA).

methodsSurvey data was collected in July 2021 in Philadelphia, Scranton, Wilkes-Barre, and Hazleton, PA. The 203 participants (38.7% Black, 27.5% Latinx) completed the 28-question survey of COVID-19 vaccination attitudes in either English or Spanish.

resultOut of the 203 participants, 181 participants met all the inclusion criteria, including completed surveys; of these participants, over three-fifths (63.5%) were acceptant of the COVID-19 vaccine whereas the remainder (36.5%) were hesitant. Binary logistic regression results showed that age, concern for vaccine efficacy, race, knowledge on the vaccine, and belief that the COVID-19 virus is serious significantly influenced COVID-19 vaccine hesitancy. Minorities were more likely to be hesitant toward vaccination (OR: 2.8, 95% CI: 1.1, 6.8) than non-Hispanic whites. Those who believed the COVID-19 vaccine was ineffective (OR: 8.3, 95% CI: 3.8, 18.2), and that the virus is not serious (OR: 8.3, 95% CI: 1.1, 61.8) showed the greatest odds of hesitancy.

conclusionsMinority status, age less than 45 years, misinformation about seriousness of COVID-19 illness, and concern about vaccine efficacy were contributing factors of COVID-19 vaccine hesitancy. Therefore, understanding and addressing the barriers to COVID-19 vaccination in minority groups is essential to decreasing transmission and controlling this pandemic, and will provide lessons on how to implement public health measures in future pandemics.

Indexed as

COVID-19EthnicityCOVID-19 VaccinesHumansMiddle AgedPandemicsPhiladelphiaVaccinationCOVID-19 Vaccines

Identifiers

PMID36745588
PMCPMC9901750
OpenAlexW4319294324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.